ALX Oncology Holdings Inc. (ALXO) Misses Q2 EPS by 6c
Tweet
Share
E-mail
Get Alerts ALXO Hot Sheet
Join SI Premium – FREE
ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q2 EPS of ($0.49), $0.06 worse than the analyst estimate of ($0.43).
For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic Signs $35b Cloud Deal With Lambda In Texas: WSJ
- PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
- Hyper Bit Technologies Announces Closing of Private Placement
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
